中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 36 Issue 10
Oct.  2020
Turn off MathJax
Article Contents

Construction and analysis of a predictive model for progressive liver fibrosis in nonalcoholic fatty liver disease based on LASSO regression

DOI: 10.3969/j.issn.1001-5256.2020.10.011
Research funding:

 

  • Received Date: 2020-03-01
  • Published Date: 2020-10-20
  • Objective To construct a noninvasive LASSO regression model based on commonly used clinical and laboratory markers associated with NAFLD,and to investigate the value of this model in the prediction and diagnosis of progressive liver fibrosis in NAFLD. Methods A total of 258 NAFLD patients who were consecutively admitted to The First Affiliated Hospital of Xi'an Medical University from January 2018 to August 2019 were enrolled,and according to liver stiffness measurement measured by FibroScan,the patients were divided into non-progressive fibrosis group with 184 patients and progressive fibrosis group with 74 patients. General information and biochemical parameters were collected. The independent samples t-test was used for comparison of normally distributed continuous data between the two groups,and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between the two groups. The chi-square test was used for comparison of categorical data between two groups. The LASSO regression algorithm was used to screen out the characteristic indicators with non-zero coefficients which were associated with progressive fibrosis,and a LASSO regression model was constructed. The area under the receiver operator characteristic curve( AUC),sensitivity,and specificity of this model were calculated,and the LASSO regression model was compared with known classic models. Results The LASSO regression analysis screened out the important variables of type Ⅳ collagen,body mass index,and aspartate aminotransferase,and a LASSO regression model was constructed based on these three indicators. The results showed that the LASSO regression model had an AUC of 0. 843( 95% confidence interval [CI]: 0. 790-0. 897),a sensitivity of 0. 851,and a specificity of 0. 810,with a significantly better AUC than APRI( AUC = 0. 791,95% CI: 0. 731-0. 850),FIB-4( AUC = 0. 426,95% CI:0. 345-0. 507),and NFS( AUC = 0. 540,95% CI: 0. 463-0. 617). Conclusion Compared with the existing noninvasive scoring system for progressive liver fibrosis in NAFLD,this regression model has better AUC,specificity,and sensitivity,with strong practicability and operability,and therefore,it can be used as a new noninvasive model for the diagnosis of liver fibrosis.

     

  • loading
  • [1] YOUNOSSI Z,TACKE F,ARRESE M,et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis[J]. Hepatology,2019,69(6):2672-2682.
    [2] YOUNOSSI ZM,KOENIG AB,ABDELATIF D,et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology,2016,64(1):73-84.
    [3] CHALASANI N,YOUNOSSI Z,LAVINE JE,et al. The diagnosis and management of non-alcoholic fatty liver disease:Practice guideline by the American Gastroenterological Association,American Association for the Study of Liver Diseases,and American College of Gastroenterology[J]. Gastroenterology,2012,142(7):1592-1609.
    [4] HAGSTROM H,NASR P,EKSTEDT M,et al. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD[J]. J Hepatol,2017,67(6):1265-1273.
    [5] VILAR-GOMEZ E,CALZADILLA-BERTOT L,WAI-SUN WONG V,et al. Fibrosis severity as a determinant of causespecific mortality in patients with advanced nonalcoholic fatty liver disease:A multi-national cohort study[J]. Gastroenterology,2018,155(2):443-457.
    [6] FENG G,HAN HJ,Ql X,et al. Establishment of a noninvasive diagnosis equation for nonalcoholic fatty liver disease[J]. J Clin Hepatol,2018,34(6):1264-1267.(in Chinese)冯巩,韩海静,齐雪,等.非酒精性脂肪性肝病无创性诊断方程的构建[J].临床肝胆病杂志,2018,34(6):1264-1267.
    [7] FENG G,HE N,ZHOU YF,et al. A simpler diagnostic formula for screening nonalcoholic fatty liver disease[J]. Clin Biochem,2019,64:18-23.
    [8] National Workshop on Fatty Liver and Alcoholic Liver Disease,Chinese Society of Hepatology,Chinese Medical Association;Fatty Liver Expert Committee,Chinese Medical Doctor Association. Guidelines of prevention and treatment for nonalcoholic fatty liver disease:A 2018 update[J]. J Clin Hepatol,2018,34(5):947-957.(in Chinese)中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南(2018年更新版)[J].临床肝胆病杂志,2018,34(5):947-957.
    [9] Expert Committee on consensus on clinical application of transient elastography(TE). Expert consensus on clinical application of transient elastography(TE)(2015)[J/CD]. Chin J Liver Dis(Electronic Version),2015,7(2):12-18.(in Chinese)瞬时弹性成像技术(TE)临床应用共识专家委员会.瞬时弹性成像技术(TE)临床应用专家共识(2015年)[J/CD].中国肝脏病杂志(电子版),2015,7(2):12-18.
    [10] NAIBANTOGLU IL,BRUNT EM. Role of liver biopsy in nonalcoholic fatty liver disease[J]. World J Gastroenterol,2014,20(27):9026-9037.
    [11] PARK CC,NGUYEN P,HERNANDEZ C,et al. Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease[J]. Gastroenterology,2017,152(3):598-607.
    [12] BEDOSSA P,PATEL K. Biopsy and noninvasive methods to assess progression of nonalcoholic fatty liver disease[J].Gastroenterology,2016,150(8):1811-1822.
    [13] PATEL PJ,CHENG JC,BANH X,et al. Clinically significant fibrosis is associated with longitudinal increases in Fibrosis-4and nonalcoholic fatty liver disease fibrosis scores[J]. Clin Gastroenterol Hepatol,2020,18(3):710-718.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1123) PDF downloads(122) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return